European Medicines Agency: Benefits of AstraZeneca vaccine continue to outweigh the risks

Reuters · 03/16/2021 13:16
European Medicines Agency: Benefits of AstraZeneca vaccine continue to outweigh the risks

- Europe's medicines watchdog on Tuesday said the benefits of AstraZeneca's AZN.L COVID-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots.

The EMA's Executive Director Emer Cooke said the agency was carrying out a case-by-case evaluation of incidents and was expected to complete a review on Thursday.


(Reporting by Anthony Deutsch; Editing by Catherine Evans)

((anthony.deutsch@thomsonreuters.com;))